Clinical trials: Doxycycline

Rosacea

ORCA - Oracea® for Rosacea: A Community-based Assessment

• Completed
• Age: 18 years and older
• Phase 4
• Results posted

The objective of this study is to assess the effectiveness, safety, subject satisfaction and quality of life with Oracea® when used as monotherapy or as add-on therapy to existing topical regimens for the treatment of rosacea.

Trial name

NCT00892281

Testing

doxycycline (Oracea®) 40 mg modified release as monotherapy, doxycycline (Oracea®) 40 mg modified release as add-on therapy

Where

United States

Volunteers

1,421 people

Sponsor

Galderma R&D